Effects of Iloprost Inhalation on Exercise Capacity and Ventilatory Efficiency in Patients With Primary Pulmonary Hypertension
- 23 May 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (20) , 2388-2392
- https://doi.org/10.1161/01.cir.101.20.2388
Abstract
Background—The continuous infusion of prostacyclin has been shown to improve exercise capacity and survival in patients with primary pulmonary hypertension (PPH). Inhalation of iloprost, a stable a...Keywords
This publication has 24 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Cardiovascular and Pulmonary Effects of Aerosolized Prostacyclin Administration in Severe Respiratory Failure Using a Ventilator Nebulization SystemJournal of Cardiovascular Pharmacology, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Acute Hemodynamic Effects of Iloprost in Primary (Unexplained) Pulmonary HypertensionSeminars in Respiratory and Critical Care Medicine, 1994
- Aerosolised prostacyclin in adult respiratory distress syndromeThe Lancet, 1993
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).Heart, 1987
- Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular diseaseJournal of the American College of Cardiology, 1984
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease.Journal of Clinical Investigation, 1979